Is Intuitive Surgical (ISRG) Fairly Priced After A 27% One Year Share Price Decline?
Intuitive Surgical, Inc. ISRG | 0.00 |
- If you are wondering whether Intuitive Surgical at around US$407 per share is pricing in too much optimism or not enough, the starting point is to understand how its current market value lines up against fundamentals.
- The stock is down 2.7% over the past week, 10.0% over the past month, and 27.5% year to date, with a 27.0% decline over the last year contrasting with longer term returns of 32.6% over three years and 45.4% over five years.
- These moves have kept Intuitive Surgical in focus as investors weigh long term adoption of robotic assisted surgery, regulatory developments, and capital spending trends in hospitals. The current price also reflects how the market is processing company specific announcements, partnerships, and broader healthcare sector sentiment.
- Simply Wall St's valuation framework currently gives Intuitive Surgical a 1/6 valuation score. The rest of this article will walk through key valuation methods and end with a more flexible way to think about what the stock could be worth.
Intuitive Surgical scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.
Approach 1: Intuitive Surgical Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow, or DCF, model takes estimates of future cash flows and discounts them back to today to estimate what the entire business could be worth in present value terms.
For Intuitive Surgical, the latest twelve month Free Cash Flow is about $2.32b. Analysts have provided explicit forecasts out to 2030, where Free Cash Flow is projected at $6.14b. Further years are extrapolated by Simply Wall St using a 2 Stage Free Cash Flow to Equity model. Those ten year projections range from about $4.27b to $8.19b, with each future value discounted back to today and summed.
On this basis, the DCF model suggests an estimated intrinsic value of roughly $406.40 per share. Against a recent share price around $407, the model implies the stock is about 0.2% higher than that intrinsic estimate, which points to Intuitive Surgical trading very close to the DCF output.
Result: ABOUT RIGHT
Intuitive Surgical is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.
Approach 2: Intuitive Surgical Price vs Earnings
For a profitable company, the P/E ratio is a useful way to see how much you are paying for each dollar of current earnings. It links directly to the business you own, because the “P” is today’s share price and the “E” is actual earnings, not just revenue or assets.
What counts as a reasonable P/E depends on how the market views a company’s growth prospects and risk. Higher expected growth or lower perceived risk can support a higher multiple, while slower growth or higher uncertainty usually calls for a lower one.
Intuitive Surgical trades on a P/E of 48.42x. This sits well above the Medical Equipment industry average of 24.30x and also above the peer group average of 24.93x. Simply Wall St’s Fair Ratio for Intuitive Surgical is 31.27x, which is a proprietary estimate of what the P/E might be given factors such as earnings growth profile, industry, profit margins, market cap and risk indicators.
Compared with simple industry or peer comparisons, the Fair Ratio gives a more tailored reference point because it adjusts for company specific characteristics rather than treating all stocks in the group as equal. With the current P/E of 48.42x sitting above the Fair Ratio of 31.27x, the stock screens as OVERVALUED on this measure.
Result: OVERVALUED
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.
Upgrade Your Decision Making: Choose your Intuitive Surgical Narrative
Earlier it was mentioned that there is an even better way to understand valuation, so Narratives are introduced as a simple way for you to attach a clear story about Intuitive Surgical to your own forecast for revenue, earnings and margins. You can then link that forecast to a Fair Value that can be compared directly with today’s price on Simply Wall St’s Community page.
Instead of only looking at the DCF or the current P/E of 48.42x, you choose or build a Narrative that reflects what you believe about Intuitive Surgical’s future. These can range from a more cautious view with a Fair Value around US$430.05 to a more optimistic view closer to US$750.00, with the consensus style Narrative in between at about US$611.82. The platform keeps that Fair Value updated when new earnings, recalls, product clearances or guidance are added, so you can quickly see whether your chosen Narrative suggests the stock looks expensive or cheap relative to the live market price.
Do you think there's more to the story for Intuitive Surgical? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
